Latest News | Biocon Biologics Gets EU GMP Certification from Ireland's HPRA

New Delhi, Jul 5 (PTI) Biocon Biologics, an arm of Biocon, on Tuesday said its Bengaluru-based manufacturing plant has received EU GMP certification from Ireland's Health Products Regulatory Authority (HPRA).

The company's new monoclonal antibodies (mAbs) drug substance manufacturing facility (B3) at Biocon Park, Bengaluru has received the certification following a GMP inspection in April 2022, a Biocon Biologics spokesperson said in a statement.

Also Read | Cryptocurrency Crash: Singapore Government Reportedly Plans Tougher Restrictions Amid Crypto Meltdown.

The facility, spread across 340,000-square feet, will enhance the company's capabilities manifold to manufacture drug substance of mAbs portfolio, the spokesperson said.

This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing, the statement added.

Also Read | OnePlus 10T Price Revealed via Amazon UK Website, Expected Features & Specifications.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)